These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5121295)

  • 1. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D; Ferretti PG; Daccò L; Mazzera F
    G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of miscleron on various indicators of blood coagulation in ischemic heart disease].
    Deriagina GP
    Kardiologiia; 1977 Mar; 17(3):141-2. PubMed ID: 886690
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A; Lampugnani P
    Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antithrombogenic action of a new extract: 3GS].
    Rusconi C; Orlando G
    Minerva Cardioangiol; 1975 Sep; 23(9):565-70. PubMed ID: 125860
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Checking of various hemostatic indices in patients with vascular diseases before and after treatment with inhibitors of platelet adhesiveness].
    Patrone F; Armani U; Boy E; Botta G; Boccaccio P
    Minerva Cardioangiol; 1975; 23(6-7):379-91. PubMed ID: 1143662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Shifts in coagulating and fibrinolytic activity of the blood following the administration of nerobol in patients with coronary atherosclerosis].
    Kratovskaia OV; Zalaldinova NB; Afaunova VI; Denisova TP; Lebedeva SN
    Ter Arkh; 1972 Sep; 44(9):29-31. PubMed ID: 4660396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of atherosclerosis with cobalt-containing preparations].
    Khodzhaev AKh; Ashirmatov AE; Mirochnik LM
    Klin Med (Mosk); 1972 Jan; 50(1):77-82. PubMed ID: 5020034
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the fibrinolytic activity of dimethylbiguanide in prevention of thromboembolism in patients with angiocardiopathy].
    Molino N; Belluardo C
    Rass Int Clin Ter; 1968 Jun; 48(11):687-700. PubMed ID: 5738544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
    Heine H; Norden K; Heinemann L; Stepanauskas M; Schmidt H
    Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is fibrinolysis critical for acute coronary syndromes?
    Kluft C; Andreotti F
    Ital Heart J; 2001 Sep; 2(9):639-40. PubMed ID: 11666088
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with hexobendine in coronary disease].
    Eral N
    Arzneimittelforschung; 1968 Aug; 18(8):1094-103. PubMed ID: 5755844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with polysponin therapy of atherosclerosis].
    Milimovka ME; Konovalov MN; Rybnikov NI; Dimant MI
    Vrach Delo; 1971 Jan; (1):63-5. PubMed ID: 5576585
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of heparin and fibrinolysin in patients with coronary arteriosclerosis].
    Aleĭnikova LI
    Vrach Delo; 1966 Mar; 3():53-6. PubMed ID: 4230197
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of Atromid-S on thrombogenic factors].
    Cotton RC
    Minerva Med; 1971 Sep; 62(72):3466-8. PubMed ID: 5097218
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.